Codex Committee on Residues of Veterinary Drugs in Foods (CCRVDF)
CL 2022/78-RVDF
12/2022
Request for comments on the recommendations arising from the Joint CCPR/CCRVDF EWG
30/01/2023
CL 2022/77-RVDF
12/2022
Request for comments on criteria and procedures for the establishment of action levels for unintended and unavoidable carryover of veterinary drugs from feed to food of animal origin
30/01/2023
CL 2021/98-RVDF
12/2021
Request for comments on proposed MRLs for veterinary drugs extrapolated to one or more species
25/03/2022
CL 2021/75-RVDF
10/2021
Request for comments on texts going for adoption by CAC (Steps 5, 5/8 and 8) – CCRVDF
05/11/2021
CL 2021/06/OCS-RVDF
04/2021
Request for comments on the recommendations for edible offal and other animal tissues of relevance for the purpose of harmonization and elaboration of maximum residue limits for compounds with dual uses
05/06/2021
CL 2021/05/OCS-RVDF
01/2021
Request for comments on the principles and procedure for the parallel review of a new veterinary drug by JECFA and national regulatory agencies
30/04/2021
CL 2020/42(REV1)-RVDF
07/2020
Request for comments / information on the: (i) approach for the extrapolation of MRLs for veterinary drugs to one or more species and (ii) proposals for MRLs based on the approach proposed for extrapolation of MRLs to one or more species
28/02/2021
CL 2020/42(REV1)-RVDF
07/2020
Request for comments / information on the: (i) approach for the extrapolation of MRLs for veterinary drugs to one or more species and (ii) proposals for MRLs based on the approach proposed for extrapolation of MRLs to one or more species
28/02/2021
EN
FR
ES
AR
ZH
RU
CL 2020/18(REV1)-RVDF
02/2020
Request for comments on the priority list of veterinary drugs for evaluation by JECFA
28/02/2021
CL 2020/17(REV1)-RVDF
02/2020
Request for comments on MRLs for veterinary drugs tissues
28/02/2021
CL 2018/38/OCS-RVDF
05/2018
Request for comments at Step 5 on the proposed draft maximum residue limit for flumethrin (honey)
10/06/2018
CL 2018/37/OCS-RVDF
05/2018
Request for comments at Step 5/8 on the proposed draft maximum residue limits for veterinary drugs: Amoxicillin (finfish fillet, muscle); Ampicillin (finfish fillet, muscle); Alufenuron (salmon and trout fillet) and Monepantel (cattle fat, kidney, liver, muscle)
10/06/2018
CL 2018/37/OCS-RVDF
05/2018
Request for comments at Step 5/8 on the proposed draft maximum residue limits for veterinary drugs: Amoxicillin (finfish fillet, muscle); Ampicillin (finfish fillet, muscle); Alufenuron (salmon and trout fillet) and Monepantel (cattle fat, kidney, liver, muscle)
10/06/2018
EN
FR
ES
AR
ZH
RU
CL 2018/36/OCS-RVDF
05/2018
Request for comments at Step 8 on the draft Risk Management Recommendation for Gentian Violet
10/06/2018
CL 2017/85/OCS-RVDF
12/2017
Request for comments at Step 3 on the proposed draft MRLs for amoxicillin (finfish fillet, muscle); ampicillin (finfish fillet, muscle); flumethrin (honey), lufenuron (salmon and trout fillet), monepantel (cattle fat, kidney, liver, muscle)
15/03/2018
CL 2017/85/OCS-RVDF
12/2017
Request for comments at Step 3 on the proposed draft MRLs for amoxicillin (finfish fillet, muscle); ampicillin (finfish fillet, muscle); flumethrin (honey), lufenuron (salmon and trout fillet), monepantel (cattle fat, kidney, liver, muscle)
15/03/2018
EN
FR
ES
AR
ZH
RU
CL 2017/72/OCS-RVDF
08/2017
Request for comments at Step 6 on the draft RMR for gentian violet
30/01/2018
CL 2016/42-RVDF
12/2016
Request for Revision/Information to the Database on Countries’ Needs for MRLs
15/12/2017
CL 2016/41-RVDF
12/2016
Request for Comments/Information on Priority List of Veterinary Drugs for Evaluation or Reevaluation by JECFA
15/02/2018
CL 2016/39/OCS-RVDF
10/2016
Request for comments at Step 5 on the proposed draft RMR for gentian violet
15/06/2017
CL 2016/38/OCS-RVDF
10/2016
Request for comments at Step 5/8 on the proposed draft MRLs for lasalocid sodium, ivermectin and teflubenzuron
15/06/2017
CL 2015/18-RVDF
06/2015
Request for comments / information on priority list of veterinary drugs for evaluation or reevaluation by JECFA
15/08/2016
CL 2015/14-RVDF
05/2015
PART B – Request for Comments at step 3: Proposed Draft Risk Management Recommendation for Gentian Violet
31/07/2016
